|
RESEARCH REVIEW COMMITTEE
- Michael Adena BS, PhD, Director, Statistical
Consultancy, Covance Pty Ltd, Canberra, Australia
- Ahmad Fuad Afdhal PhD, CEO, AFA Communiction, Jakarta,
Indonesia
- Graily Aldridge BSc (Hons), M-TAG Pty Ltd, Chatswood, Australia Sang-Cheol Bae MD, MPH, PhD,
Professor, Hanyang University, Seoul, South Korea
- Heng
Bee Hoon MSc, Principal Epidemologist, National
Healthcare Group, Singapore, Singapore Bernard van den
Berg PhD, Economist, University of Technology, Sydney,
NSW, Australia
- Mary-Ann Bonney BSc, MSc, Health
Economics Project Leader, Novartis Pharmaceuticals
Australia, Sydney, NSW, Australia
- Usa Chaikledkaew PhD, Faculty Member, Mahidol University, Bangkok,
Thailand
- Nathorn Chaiyakunapruk PharmD, PhD, Assistant
Professor, Naresuan University, Phitsanulok, Thailand
- Ku-Chou Chang MD, Assistant Professor, Chang Gung
Memorial Hospital, Kaohsiung County, Taiwan
- Li-Jen
Cheng PhD, USA Anthony DeCastella Dip, App, Sc, BA,
Alfred Psychiatry Research Centre, Melbourne,
Australia
- Andrew Eggleston MSc, RPh, Associate
Director Health Economics, Janssen-Cilag Pty Ltd,
North Ryde, NSW, Australia
- Karen Eggleston PhD,
Professor, Department of Economics, Tufts University,
Boston, MA, USA
- Alex Zhenghong Fu PhD, Professor,
Pharmaceutical Policy and Evaluative Sciences, UNCChapel Hill, Chapel Hill, NC, USA
- Takashi Fukuda
PhD, Associate Professor, Graduate School of
Pharmaceutical Sciences, University of Tokyo, Tokyo,
Japan
- Yuji Inoue MD, PhD, Professor and Chairman,
Yamaguchi University School of Medicine, Yamaguchi,
Japan
- Huanguang (Charlie) Jia MPH, PhD, Research
Health Scientist, US Department of Veterans Affairs
Outcomes Research Center of Excellence, Baltimore, MD,
USA
- Hye-Young Kang PhD, Assistant Professor, Graduate
School of Public Health, Yonsei University, Seoul,
South Korea
- Makoto Kobayashi M. Eng, Manager, CRECON
Research & Consulting Inc, Tokyo, Japan Hiroyo
Kuwabara MPH, Medical Research Associate, AstraZeneca
K.K, Tokyo, Japan
- Tang Ching Lau MD, MSc, Consultant
Rheumatologist, Tan Tock Seng Hospital, Singapore,
Singapore
- Dae Hee Lee MD, MPH, Health Economics
Manager, Aventis Pharma Co., Ltd., Seoul, South Korea
- Tae-Jin Lee PhD, Assistant Professor, Department of
Social & Preventative Medicine, Chuncheon, South Korea
- Sang-IL Lee, University of Ulsan College of Medicine,
Seoul, South Korea
- Shu Chuen Li BSc, MBA, MSc, PhD,
Assistant Professor, National University of Singapore,
Singapore, Singapore
- Boon Peng Lim RPh, Pharmacist, National
Healthcare Group, Singapore, Singapore
- Ya-Ming Liu PhD, Assistant Professor,
National Cheng Kung University, Department of
Economics, Tainan, Taiwan
- Meaghan Lynch BSc, MSc, Economist, M-TAG,
Chatswood, Australia
- Grace Malanos PharmD, Head, Health
Economics, Roche Products Pty Limited, Dee Why, NSW,
Australia
- Sharon Meere, Project Manager, Health
Economics, Janssen-Cilag, North Ryde, NSW, Australia
- Vinita Nand PhD, Grad, Cert, Janssen-Cilag
Pty Ltd, North Ryde, NSW, Australia
- Yasushi Ohkusa PhD, Surveillance Center,
National Institute of Infectious Deseases, Tokyo,
Japan
- Michael Ortiz BSc, MSc, PhD, RPh,
Associate Director Health Outcomes, Sanofi-
Synthelabo, North Ryde, NSW, Australia
- Petcharat Pongcharoensuk PhD, Associate
Professor, Mahidol University, Bangkok, Thailand
- Mark Schulz PhD, Senior Health Outcomes
Manager, Merck Sharp & Dohme (Australia) Pty
Limited, Granville, NSW, Australia
- Paul A Scuffham PhD, Director, University
of Queensland, Brisbane, Australia Amelia Shann BSc,
Health Economist, Schering-Plough, Sydney, NSW,
Australia
- Lizheng Shi PhD, MsPharm, School of
Publicd and Tropical Medicine, Tulane University,
New Orleans, LA, USA
- Takuro Shimbo MD, Associate Professor,
Department of Clinical Epidemiology, Kyoto, Japan
- Cha-onsin Sooksriwong B.Sc. (Pharm)D,
Associate Professor, Department of Pharmacy, Faculty
of Pharm, Bangkok, Thailand
- Xin Sun MSc, West China Hospital, Sichuan
University, Chengdu, China Yi-Wen (Ivy) Tsai,
National Health Research Institutes, Taipei, Taiwan
- Hsu-Min Tseng PhD, Head of Department of
Healthcaree Managemetn, Chang Gung University,
Taoyuen Hsien, Taiwan
- Hong Wang, Professor, Yale University New
Haven Medical Center, New Haven, CT, USA
- Michael Wonder BSc, Senior Health
Economist, Novartis Pharmaceuticals Australia, North
Ryde, NSW, Australia
- Jipan Xie PhD, Centers for Disease
Control and Prevention, Atlanta, GA, USA
- Feng Xie MSc, Graduate Student, National
University of Singapore, Singapore, Singapore
Shuichi Yajima, Manager for Marketing Office, Taiho
Pharmaceutical Co, Ltd, Tokyo, Japan
- Tetsuji Yamada PhD, Professor, Department
of Economics, Tufts University, Boston, MA, USA
- Lijing Yan PhD, Professor, Peking University,
Beijing, China
- Shinichiro Yanagisawa MCS, Research
Associate, Research Center for Urban Safeth and
Security, Kobe University, Kobe, Japan
- Harry Qi Zhang PhD, Professor, The
University of Chicago, Chicago, IL, USA
- Zhongyun Zhao PhD, Health Outcomes
Research Scientist, Global Health Outcomes, Eli
Lilly and Company, Indianapolis, IN, USA
|
